Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
19.77
-0.17 (-0.85%)
At close: Mar 28, 2025, 4:00 PM
19.47
-0.30 (-1.51%)
After-hours: Mar 28, 2025, 7:00 PM EDT

Structure Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Selling, General & Admin
49.4132.6716.378.593.54
Research & Development
108.8170.136.1929.1112.36
Operating Expenses
158.23102.7852.5637.715.91
Operating Income
-158.23-102.78-52.56-37.7-15.91
Interest Expense
----0.12-
Interest & Investment Income
36.0113.391.26-0.17
Pretax Income
-122.22-89.38-51.3-37.82-15.74
Income Tax Expense
0.310.240.020.230.14
Net Income
-122.53-89.62-51.32-38.05-15.88
Preferred Dividends & Other Adjustments
--1.525.720.16
Net Income to Common
-122.53-89.62-52.84-43.77-16.04
Shares Outstanding (Basic)
5337332
Shares Outstanding (Diluted)
5337332
Shares Change (YoY)
43.31%1049.81%17.72%30.01%-
EPS (Basic)
-2.33-2.44-16.54-16.13-7.68
EPS (Diluted)
-2.33-2.44-16.54-16.13-7.68
Free Cash Flow
-117.93-81.66-46.28-33.37-14.3
Free Cash Flow Per Share
-2.24-2.22-14.48-12.30-6.85
EBITDA
-157.23-102.46-52.28-37.62-
D&A For EBITDA
10.320.280.07-
EBIT
-158.23-102.78-52.56-37.7-15.91
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q